FDA Inspection 956512 — Tianjin Zhongan Pharmaceutical Co., Ltd.
The FDA completed an inspection of Tianjin Zhongan Pharmaceutical Co., Ltd. on February 2, 2016 in Tianjin. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 2, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tianjin (China)